CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Revenues:
Total revenues	$ 5,932,576	$ 6,060,530	$ 4,316,363
Expenses:
General and administrative	238,536	268,912	285,760
Depreciation and amortization	28,594	24,463	16,043
Impairments	36,085	3,596	0
Total expenses	6,395,812	6,352,660	4,548,496
Income (loss) from operations	(463,236)	(292,130)	(232,133)
Other income (expense):
Income (loss) from equity method investments	(1,835)	14,992	16,489
Other income (expense), net	67,616	34,489	27,840
Interest expense	(6,641)	(6,177)	(6,658)
Income (loss) before income taxes	(404,096)	(248,826)	(194,462)
Income tax benefit (expense)	(1,251)	(1,451)	(791)
Income (loss) from continuing operations	(405,347)	(250,277)	(195,253)
Discontinued operations:
Income (loss) before gain (loss) on sales	0	(1,061)	(20,002)
Gain (loss) and adjustments on sales of assets, net	14,000	(8,763)	(47,548)
Total discontinued operations	14,000	(9,824)	(67,550)
Net income (loss)	(391,347)	(260,101)	(262,803)
Noncontrolling interests’ share in (earnings) loss	0	(50)	207
Net income (loss) attributable to common shares	$ (391,347)	$ (260,151)	$ (262,596)
Net income (loss) per common share, basic and diluted
Continuing operations basic (in dollars per share)	$ (0.98)	$ (0.61)	$ (0.48)
Continuing operations diluted (in dollars per share)	(0.98)	(0.61)	(0.48)
Discontinued operations basic (in dollars per share)	0.03	(0.02)	(0.16)
Discontinued operations diluted (in dollars per share)	$ 0.03	$ (0.02)	$ (0.16)
Weighted average shares outstanding, basic (in shares)	413,969	410,966	408,917
Weighted average shares outstanding, diluted (in shares)	413,969	410,966	408,917
Medical services revenue
Revenues:
Total revenues	$ 5,921,341	$ 6,047,715	$ 4,307,350
Expenses:
Expenses	5,977,906	5,842,530	4,008,659
Other operating revenue
Revenues:
Total revenues	11,235	12,815	9,013
Expenses:
Expenses	$ 114,691	$ 213,159	$ 238,034